Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000489382 | SCV000577046 | uncertain significance | not specified | 2017-04-12 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the FKRP gene. The A188V variant has not been published as pathogenic or been reported as benign to our knowledge. This variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Nevertheless, the A188V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Additionally, this substitution occurs at a position that is not conserved. Furthermore, in silico analysis predicts this variant likely does not alter the protein structure/function. |
Genetic Services Laboratory, |
RCV000489382 | SCV000594780 | uncertain significance | not specified | 2015-12-31 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001242700 | SCV001415803 | uncertain significance | Walker-Warburg congenital muscular dystrophy | 2022-08-23 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 188 of the FKRP protein (p.Ala188Val). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with FKRP-related conditions. ClinVar contains an entry for this variant (Variation ID: 426570). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002350087 | SCV002654240 | uncertain significance | Cardiovascular phenotype | 2022-06-22 | criteria provided, single submitter | clinical testing | The p.A188V variant (also known as c.563C>T), located in coding exon 1 of the FKRP gene, results from a C to T substitution at nucleotide position 563. The alanine at codon 188 is replaced by valine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002475962 | SCV002775849 | uncertain significance | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1; Muscular dystrophy-dystroglycanopathy type B5; Autosomal recessive limb-girdle muscular dystrophy type 2I; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 | 2021-10-14 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003144287 | SCV003832644 | uncertain significance | not provided | 2020-02-24 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834588 | SCV002088961 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2020-12-01 | no assertion criteria provided | clinical testing |